NORMAL SITUATION

PHARMAFIN

Financial year 2024 · closed on 30/09/2024
Net result
431,1 k €
+336.0% YoY
Gross margin
511,3 k €
+253.7% YoY
Equity
899,3 k €
+78.8% YoY

Company — Normal situation.

What does PHARMAFIN do?

PHARMAFIN is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0808.755.910
Legal form
Private limited company
Contributed capital
74 000,00 €
Latest accounts
30/09/2024
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 13 financial years

2024202320222021201820172016201520142013201220112010
Income statement
Gross margin511,3 k €144,6 k €127,5 k €60,7 k €64,7 k €75 k €56,4 k €73,9 k €73,9 k €58 k €50,7 k €48 k €85,5 k €
EBITDA510,6 k €143,1 k €127 k €60,1 k €63,7 k €73,8 k €55,4 k €72,6 k €72,9 k €56,9 k €49,7 k €45,7 k €84,6 k €
Operating result510,4 k €142,9 k €126,7 k €59,8 k €62 k €72,1 k €53,7 k €71 k €71,3 k €56,9 k €49,7 k €45,7 k €83,7 k €
Net result431,1 k €98,9 k €89,5 k €40,9 k €34,7 k €27,2 k €16,6 k €41,1 k €41 k €33,3 k €22,1 k €19,9 k €45,3 k €
Balance sheet
Equity899,3 k €503 k €431,2 k €431,4 k €291,5 k €256,8 k €229,6 k €212,9 k €171,8 k €138 k €104,7 k €82,6 k €65,3 k €
Total assets1,2 M €651,4 k €528,7 k €515,6 k €484,7 k €476,9 k €485,2 k €504,2 k €493,8 k €432,2 k €432,6 k €475,6 k €485,1 k €
Cash1,1 M €155,3 k €51,7 k €38,4 k €12,2 k €6,4 k €2,2 k €17 k €3,6 k €15,8 k €11,8 k €45,2 k €79,2 k €
Debts256,1 k €148,4 k €97,5 k €82,1 k €188,4 k €215 k €253,4 k €287,8 k €321,9 k €294,2 k €327,9 k €391,6 k €418,3 k €
Governance

Board of directors

Seen on filing of 30/09/2024 · 2 active · 5 ended

Active mandates

Filip Moens

Director · since 20 décembre 2008

Active
Kristel De Leeneer

Director · since 20 décembre 2008

Active

Ended mandates

Filip Moens

Director

Ended
Kristel De Leeneer

Director

Ended
Kristel De Leeneer

Manager

Ended
Leeneer Kristel De

Manager

Ended
Annual accounts

Full financial information

202420232022202120202019
Type of accountMicro modelMicro modelMicro modelAbridged modelAbridged modelAbridged model
Start of the financial year01/10/202301/10/202201/10/202101/10/202001/10/201901/10/2018
Closing of the financial year30/09/202430/09/202330/09/202230/09/202130/09/202030/09/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/12/202416/04/202428/03/202326/04/202227/04/202130/04/2020
General meeting09/12/202415/03/202417/03/202330/03/202231/03/202131/03/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

15 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/09/202409/12/202423/12/2024DutchPDF
Micro model30/09/202315/03/202416/04/2024DutchPDF
Micro model30/09/202217/03/202328/03/2023DutchPDF
Abridged model30/09/202130/03/202226/04/2022DutchPDF
Abridged model30/09/202031/03/202127/04/2021DutchPDF
Abridged model30/09/201931/03/202030/04/2020DutchPDF
Abridged model30/09/201831/03/201912/04/2019DutchPDF
Abridged model30/09/201730/03/201825/04/2018DutchPDF
Abridged model30/09/201617/03/201731/03/2017DutchPDF
Abridged model30/09/201518/03/201622/03/2016DutchPDF
Abridged model30/09/201420/03/201515/04/2015DutchPDF
Abridged model30/09/201321/03/201410/04/2014DutchPDF
Abridged model30/09/201230/03/201330/04/2013DutchPDF
Abridged model30/09/201129/03/201226/04/2012DutchPDF
Abridged model30/09/201030/03/201129/04/2011DutchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/09/2024 · 2 active · 5 ended

Active mandates

Filip Moens

Director · since 20 décembre 2008

Active
Kristel De Leeneer

Director · since 20 décembre 2008

Active

Ended mandates

Filip Moens

Director

Ended
Kristel De Leeneer

Director

Ended
Kristel De Leeneer

Manager

Ended
Leeneer Kristel De

Manager

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Dissolution08/01/2025
    RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
    PDF
  • Mandates28/12/2023
    WIJZIGING RECHTSVORM - DOEL - ONTSLAGEN - BENOEMINGEN
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024431,1 k €
  2. 2023
    Annual accounts 202398,9 k €
  3. 2022
    Annual accounts 202289,5 k €
  4. 2021
    Annual accounts 202140,9 k €
  5. 2018
    Annual accounts 201834,7 k €
  6. 2017
    Annual accounts 201727,2 k €
  7. 2016
    Annual accounts 201616,6 k €
  8. 2015
    Annual accounts 201541,1 k €
  9. 2014
    Annual accounts 201441 k €
  10. 2013
    Annual accounts 201333,3 k €
  11. 2012
    Annual accounts 201222,1 k €
  12. 2011
    Annual accounts 201119,9 k €
  13. 2010
    Annual accounts 201045,3 k €